Ross Muken

CIK: 0002005463

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)14 (93.3%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (6.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

SOPH

SOPHiA GENETICS SA

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (15 total)

SOPH
SOPHiA GENETICS SA
Oct 5, 2026
Sale(S)
Direct
9.8K shares at avg. $8.13$80K
SOPH
SOPHiA GENETICS SA
Sep 21, 2026
Sale(S)
Direct
422 shares at avg. $8.33$4K
SOPH
SOPHiA GENETICS SA
Jul 6, 2026
Sale(S)
Direct
9.8K shares at avg. $5.22$51K
SOPH
SOPHiA GENETICS SA
Jun 22, 2026
Sale(S)
Direct
422 shares at avg. $5.38$2K
SOPH
SOPHiA GENETICS SA
May 19, 2026
Sale(S)
Direct
761 shares at avg. $4.60$4K
SOPH
SOPHiA GENETICS SA
Apr 20, 2026
Sale(S)
Direct
760 shares at avg. $5.20$4K
SOPH
SOPHiA GENETICS SA
Apr 14, 2026
Sale(S)
Direct
2.8K shares at avg. $4.96$14K
SOPH
SOPHiA GENETICS SA
Apr 13, 2026
Sale(S)
Direct
4.4K shares at avg. $4.76$21K
SOPH
SOPHiA GENETICS SA
Apr 10, 2026
Sale(S)
Direct
3.7K shares at avg. $4.69$17K
SOPH
SOPHiA GENETICS SA
Apr 9, 2026
Sale(S)
Direct
2K shares at avg. $4.74$9K
SOPH
SOPHiA GENETICS SA
Apr 8, 2026
Sale(S)
Direct
2.8K shares at avg. $4.84$13K
SOPH
SOPHiA GENETICS SA
Apr 7, 2026
Sale(S)
Direct
2.4K shares at avg. $4.87$12K
SOPH
SOPHiA GENETICS SA
Apr 6, 2026
Sale(S)
Direct
2.6K shares at avg. $4.85$13K
SOPH
SOPHiA GENETICS SA
Apr 2, 2026
Award(A)
Direct
431.2K shares-
SOPH
SOPHiA GENETICS SA
Mar 19, 2026
Sale(S)
Direct
1.2K shares at avg. $4.79$6K

		Type	Shares	Price		Ownership
Oct 5, 2026	SOPH SOPHiA GENETICS SA	Sale(S)	9,838	$8.13	$79,971	Direct
Sep 21, 2026	SOPH SOPHiA GENETICS SA	Sale(S)	422	$8.33	$3,515	Direct
Jul 6, 2026	SOPH SOPHiA GENETICS SA	Sale(S)	9,838	$5.22	$51,354	Direct
Jun 22, 2026	SOPH SOPHiA GENETICS SA	Sale(S)	422	$5.38	$2,270	Direct
May 19, 2026	SOPH SOPHiA GENETICS SA	Sale(S)	761	$4.60	$3,501	Direct
Apr 20, 2026	SOPH SOPHiA GENETICS SA	Sale(S)	760	$5.20	$3,955	Direct
Apr 14, 2026	SOPH SOPHiA GENETICS SA	Sale(S)	2,800	$4.96	$13,887	Direct
Apr 13, 2026	SOPH SOPHiA GENETICS SA	Sale(S)	4,442	$4.76	$21,166	Direct
Apr 10, 2026	SOPH SOPHiA GENETICS SA	Sale(S)	3,687	$4.69	$17,279	Direct
Apr 9, 2026	SOPH SOPHiA GENETICS SA	Sale(S)	1,950	$4.74	$9,239	Direct
Apr 8, 2026	SOPH SOPHiA GENETICS SA	Sale(S)	2,786	$4.84	$13,488	Direct
Apr 7, 2026	SOPH SOPHiA GENETICS SA	Sale(S)	2,424	$4.87	$11,801	Direct
Apr 6, 2026	SOPH SOPHiA GENETICS SA	Sale(S)	2,600	$4.85	$12,603	Direct
Apr 2, 2026	SOPH SOPHiA GENETICS SA	Award(A)	431,211	-	$0	Direct
Mar 19, 2026	SOPH SOPHiA GENETICS SA	Sale(S)	1,183	$4.79	$5,671	Direct

1-15 of 15 transactions

About Muken Ross

Muken Ross (SEC CIK 0002005463) files insider reports with the SEC as Chief Executive Officer of SOPHiA GENETICS SA (SOPH).

Signal8 holds 14 ownership filings by Muken Ross (1 Form 3, 13 Form 4), filed between Mar 18, 2026 and Oct 7, 2026. Those filings report 15 transactions, from Mar 19, 2026 to Oct 5, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Muken Ross's filings is in BOSTON, MA.

Recent filings by Muken Ross

Oct 5, 2026: Open-market sale of SOPH shares (Form 4, code S).
Sep 21, 2026: Open-market sale of SOPH shares (Form 4, code S).
Jul 6, 2026: Open-market sale of SOPH shares (Form 4, code S).
Jun 22, 2026: Open-market sale of SOPH shares (Form 4, code S).
May 19, 2026: Open-market sale of SOPH shares (Form 4, code S).

Other insiders filing for SOPHiA GENETICS SA (SOPH)

Menu Philippe, Chief Medical Officer
Xu Zhenyu, Chief Scientific Officer
Camblong Jurgi, Executive Chairman
Van Well Daan, Chief Legal Officer
Valente Manuela, Chief People Officer
Verma Abhimanyu, Chief Technology Officer

How to read Form 4 transaction codes